Spinal Tech

RTI Biologics Named Stryker’s Dean Bergy to Board of Directors

Dean H. Bergy, advisor to the chief financial officer at Stryker, has become a member of the RTI Biologics board of directors, according to an RTI Biologics news release.

Laura Dyrda

Friday, July 23rd, 2010

Previously, Mr. Bergy served as vice president of finance and chief accounting officer, vice president of finance for the medical division and corporate controller at Stryker.

He will be up for re-election in 2012.

Read the RTI Biologics release on Dean Bergy.

Read other coverage on RTI Biotics.

-RTI Biologics Develops Reimbursement Hotline for Sports Medicine

-RTI Biologics Posts 11% Higher Revenues in Third Quarter, a Record

Next Up in Spinal Tech

Where AI 'actually makes a difference' in spine care: Dr. David Skaggs

AI in spine care has been commonly leveraged to support administrative tasks, but one of its real potentials lies in…

By: Carly Behm
Wednesday, November 19th, 2025
Stryker net sales up 10.3% in Q3: 5 notes

Medtech company Stryker reported sales increases across multiple portfolios in the third quarter, according to financial results posted Oct. 30.…

By: Ariana Portalatin
Friday, October 31st, 2025
4 spine FDA nods in October

Here are four companies earning FDA clearance for spine technology this month: 1. Elevation Spine’s Saber-C earned FDA clearance for…

By: Ariana Portalatin
Friday, October 31st, 2025

Comments are closed.

Stop Buying Recommendations. Start Buying Results: Why more hospitals are replacing traditional consulting with managed partnerships

Next Up in Spinal Tech

Where AI 'actually makes a difference' in spine care: Dr. David Skaggs

Stryker net sales up 10.3% in Q3: 5 notes

4 spine FDA nods in October

Join the spine leaders & surgeons who start their day with Becker's